Results 251 to 260 of about 395,539 (294)
This study aimed to investigate the molecular pathways involved in the health benefits of chronic orange juice (OJ) consumption through global transcriptomic approach in peripheral blood mononuclear cells (PBMCs). Healthy volunteers consumed 500 mL of OJ daily for 60 days.
Layanne Nascimento Fraga +6 more
wiley +1 more source
DTI-ALPS index as a predictor of glymphatic system dysfunction in cerebral infarction. [PDF]
Lin B, Leong YY, Mohamad M.
europepmc +1 more source
Acute hemichorea‐hemiballism as the initial sign of cortical cerebral infarction: A case report
Abstract Hemichorea‐hemiballism is classically associated with the contralateral basal ganglia, particularly involving the putamen and subthalamic nucleus, whereas cortical involvement remains a rare etiology. In this case, we present a patient with acute hemichorea‐hemiballism secondary to multiple cortical infarcts demonstrated by neuroimaging.
Jin Xiong +5 more
wiley +1 more source
A commentary on "Anatomical predispositions for silent cerebral infarction postcarotid artery stenting: a retrospective cohort". [PDF]
Li C, Qi M.
europepmc +1 more source
Neuro-Behcet Disease with Recurrent Cerebral Infarction-A case report-
Sung-Ryeol Ju +3 more
openalex +1 more source
Microglia Display Altered Spatial Morphology and Proteome After Stroke
ABSTRACT Microglia are abundantly distributed throughout the central nervous system (CNS) to play critical roles in neural development and homeostasis, and act as immune sentinels to constantly monitor their surrounding neural environment. Given their high reactivity to brain insults, we hypothesised that the cerebral microenvironment altered by ...
Brooke J. Wanrooy +10 more
wiley +1 more source
Multiparametric MRI detection of cerebral metabolism: a tool for early differentiation between MELAS and ischemic cerebral infarction. [PDF]
Yang X +6 more
europepmc +1 more source
Population Pharmacokinetics of Asundexian in People at Risk for Thromboembolic/Cardiovascular Events
ABSTRACT Asundexian is a potent, selective, and reversible inhibitor of activated clotting Factor XI currently under development for secondary prevention of recurrent ischemic stroke in the ongoing Phase III OCEANIC‐STROKE study (NCT05686070). Here, we report the development of a population pharmacokinetic (popPK) model for asundexian.
Ashraf Yassen +7 more
wiley +1 more source

